Daily BriefsECM

Daily Brief ECM: Samsung SDI: Announces a 2 Trillion Won Rights Offering Capital Raise and more

In today’s briefing:

  • Samsung SDI: Announces a 2 Trillion Won Rights Offering Capital Raise
  • Bama Tea Pre-IPO – Fourth Attempt to Go Public
  • Bluestone Jewellery and Lifestyle Pre-IPO – Strong Growth but with Cash Flow Struggles
  • DN Solutions IPO Preview
  • Duality Biotherapeutics (映恩生物) Pre-IPO: PHIP Updates Show Slight Improvements


Samsung SDI: Announces a 2 Trillion Won Rights Offering Capital Raise

By Douglas Kim

  • On 14 March, Samsung SDI (006400 KS) announced a 2 trillion won (US$1.4 billion) rights offering capital raise plan.
  • Samsung SDI’s 2 trillion won capital raise is likely to have a near-term negative impact on the company’s share price.
  • We are negative on Samsung SDI’s rights offering capital raise mainly due to shares dilution. We also remain concerned that weak demand for EVs globally could last longer. 

Bama Tea Pre-IPO – Fourth Attempt to Go Public

By Troy Wong

  • Bama Tea (BT) is looking to raise at least US$100m in its upcoming Hong Kong IPO.
  • BT mainly grew through franchising. Its broad portfolio boosts market reach. A shift to online sales and stable tea prices may improve gross margins.
  • BT needs capital for expansion but faces challenges: a fragmented, slow-growing industry, declining franchise earnings, weak 9M24 tea-leaf sales, supplier/customer concentration, and this being BT’s fourth attempt at going public.

Bluestone Jewellery and Lifestyle Pre-IPO – Strong Growth but with Cash Flow Struggles

By Rosita Fernandes

  • Bluestone Jewellery and Lifestyle Ltd Ltd (BJL) (0124165D IN)(BJL) is planning to raise about US$118m in its upcoming India IPO. 
  • BJL offers contemporary lifestyle diamond, gold, platinum, and studded jewellery under its flagship brand.
  • It is a digital-first direct-to-consumer (DTC) brand and is the second largest digital-first omni-channel jewellery brand in India in terms of revenue for FY24, as per RedSeer Report.

DN Solutions IPO Preview

By Douglas Kim

  • DN Solutions is getting ready to complete its IPO in Korea in May 2025. The IPO price range is from 65,000 won to 89,700 won.
  • The book building for the institutional investors will last from 22 to 28 April. The expected IPO offering amount is from 1.14 trillion won to 1.57 trillion won.
  • The IPO price range is based on DN Solutions’ net profit of 317.4 billion won, P/E of 25.2x, and IPO discount rates of 29.1% to 48.6%.

Duality Biotherapeutics (映恩生物) Pre-IPO: PHIP Updates Show Slight Improvements

By Ke Yan, CFA, FRM

  • Duality Biotherapeutics, a China-based clinical-stage biotechnology company, plans to raise up to US$300m via a Hong Kong listing.
  • The company has passed the hearing for the listing and filed a new version of the prospectus.
  • We look at the difference between previous filing and current filing.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars